Patents by Inventor Michael N. Needle

Michael N. Needle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of tivozanib to treat subjects with refractory cancer
    Patent number: 11504365
    Abstract: Disclosed is a method of treating cancer, e.g., refractory cancer, with tivozanib. The methods disclosed include, for example, administering tivozanib as a second or third-line therapy to subjects suffering from refractory advanced renal cell carcinoma where traditional therapies as well as more recent targeted and immune-oncology therapies have not adequately treated the subject.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: November 22, 2022
    Assignee: AVEO Pharmaceuticals, Inc.
    Inventors: Michael P. Bailey, Michael N. Needle
  • USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER
    Publication number: 20220233516
    Abstract: Disclosed is a method of treating cancer, e.g., refractory cancer, with tivozanib. The methods disclosed include, for example, administering tivozanib as a second or third-line therapy to subjects suffering from refractory advanced renal cell carcinoma where traditional therapies as well as more recent targeted and immune-oncology therapies have not adequately treated the subject.
    Type: Application
    Filed: April 14, 2022
    Publication date: July 28, 2022
    Inventors: Michael P. Bailey, Michael N. Needle
  • USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER
    Publication number: 20220000858
    Abstract: Disclosed is a method of treating cancer, e.g., refractory cancer, with tivozanib. The methods disclosed include, for example, administering tivozanib as a second or third-line therapy to subjects suffering from refractory advanced renal cell carcinoma where traditional therapies as well as more recent targeted and immune-oncology therapies have not adequately treated the subject.
    Type: Application
    Filed: November 5, 2019
    Publication date: January 6, 2022
    Inventors: Michael P. Bailey, Michael N. Needle